Kashine Susumu, Kishida Ken, Funahashi Tohru, Yasuda Tetsuyuki, Okita Kohei, Matsuzawa Yuji, Shimomura Iichiro
Department of Metabolic Medicine, Osaka University, Japan.
Intern Med. 2011;50(18):1895-903. doi: 10.2169/internalmedicine.50.5669. Epub 2011 Sep 15.
Sleep-disordered breathing (SDB) is a potential risk factor for cardiac sudden death. Recent studies have reported that patients with type 2 diabetes mellitus (T2DM) frequently suffer from SDB. Although the roles of hyperglycemia, disturbances of the autonomic nervous system and obesity have been postulated, the factors related to SDB in T2DM, especially those related to improvement of SDB remain unknown. We investigated the significance of waist circumference (WC), representing excess visceral fat, body mass index (BMI), glycemic control and other clinical parameters on SDB in T2DM.
Forty inpatients received treatment for T2DM. Overnight cardiorespiratory monitoring and laboratory tests were conducted before and after treatment of T2DM.
The apnea-hypopnea index (AHI) at admission correlated positively with BMI, neck circumference, WC, and systolic and diastolic blood pressures, but not with Log 1,5-anhydro-D-glucitol (1,5-AG) and presence or absence of diabetic neuropathy. Stepwise multiple regression analysis identified BMI and WC as significant determinants of AHI. After 2 or 3 weeks of glucose-lowering therapy, hyperglycemia was controlled and significant reductions in AHI, BMI, WC, 1,5-AG, leptin, high-sensitivity C-reactive protein (hs-CRP), and an oxidative stress marker, thiobarbituric acid reactive substances (TBARS) were observed. The fall in AHI correlated significantly with changes in WC independent of BMI, 1,5-AG, leptin, hs-CRP, and TBARS.
Our results demonstrated that reduction of WC correlated with improvement in SDB independent of glycemic control in T2DM, and that abdominal obesity might be a target for the treatment of SDB and prevention of potential cardiovascular diseases in T2DM.
睡眠呼吸紊乱(SDB)是心源性猝死的一个潜在危险因素。最近的研究报道,2型糖尿病(T2DM)患者经常患有SDB。尽管已推测高血糖、自主神经系统紊乱和肥胖的作用,但T2DM中与SDB相关的因素,尤其是与SDB改善相关的因素仍不清楚。我们研究了代表内脏脂肪过多的腰围(WC)、体重指数(BMI)、血糖控制及其他临床参数对T2DM患者SDB的意义。
40例T2DM住院患者接受治疗。在T2DM治疗前后进行夜间心肺监测和实验室检查。
入院时的呼吸暂停低通气指数(AHI)与BMI、颈围、WC、收缩压和舒张压呈正相关,但与1,5-脱水-D-葡萄糖醇(1,5-AG)及糖尿病神经病变的有无无关。逐步多元回归分析确定BMI和WC是AHI的重要决定因素。降糖治疗2或3周后,高血糖得到控制,AHI、BMI、WC、1,5-AG、瘦素、高敏C反应蛋白(hs-CRP)及氧化应激标志物硫代巴比妥酸反应物质(TBARS)均显著降低。AHI的下降与WC的变化显著相关,且独立于BMI、1,5-AG、瘦素、hs-CRP和TBARS。
我们的结果表明,在T2DM中,WC的降低与SDB的改善相关,且独立于血糖控制,腹部肥胖可能是T2DM中SDB治疗及预防潜在心血管疾病的靶点。